Who we are

The Pasteur Network is a vast human and scientific community with more than 30 members in over 20 countries contributing together to global health.

The Pasteur Network is a vast human and scientific community with more than 30 members in over 20 countries contributing together to the improvement of global health. By pooling scientific, human and technical resources among its members, the Pasteur Network acts as a synergistic entity to address major scientific and public health challenges.

Members share strategic priorities such as epidemic and pandemic intelligence and preparedness, supporting the research and development and innovation ecosystem. They include support to diverse multi-disciplinary communities of knowledge fostering global and regional mobility and promotion of excellence in basic and translational research. Located in the heart of endemic areas, the Network has privileged access to a large number of pathogens that it monitors and studies on all five continents. This exceptional diversity makes the Pasteur Network a unique global actor in public health, science, innovation, and education, especially in the fight against infectious diseases.



The Pasteur Network connects men and women contributing daily to improve human health through their commitment, carried out jointly and adapted to the specificities of each region represented by the Network members, on the following actions:

  • Biomedical Research
  • Public Health Activities
  • Education and Training
  • Business Development and Technology Transfer

These activities are carried out to promote sustainable development, based on developing local capacities with respect for human rights and the environment.


Pasteur Network members are structures, with or without legal entity status, which have been established by either the Institut Pasteur or other organisations and which, to varying degrees, united by the association.

The association, previously known as the Pasteur International Network, was created in 2011 under the French law of 1901, and to this day is the legal representation of the Network. It is also the available structure to help its members creating, implementing and coordinating research projects amongst them. The association also ensures the organisation of regional and inter-regional interactions.

The foundation contributes to the Pasteur Network’s development through capacity building and infrastructure-strengthening activities.

The association and the sheltered foundation complement and work in perfect synergy for the benefit of the members of the Pasteur Network.

Scientific strategy

Pasteur Network is a unique model of collaboration and represents an outstanding base from which to develop international scientific cooperation. The Pasteur Network adopted an ambitious collective scientific strategy in 2017 to strengthen its position and promote its role as a global actor in public health.

Four key scientific priorities have been identified, stemming from an in-depth analysis of the specificities and assets of the Pasteur Network, making this unique model of cooperation constantly evolve.

This scientific strategy will evolve to adapt to new challenges on the global level and its success depends on the pooling of resources and data, as well as the sharing of knowledge, resources, and cutting-edge technology amongst the Pasteur Network members. The strategy is assessed and evaluated by the association to maintain transparency by different governing bodies: the Scientific Advisory Committee and the General Assembly.

Tete de moustique femelle Aedes albopictus, vecteur du virus de la dengue et du chikungunya.

Four scientific priorities

1. Exploring the principal endemic and emergent zoonoses according to the One Health approach, using the Network privileged global locations giving it access to benefit from its diversity.

2. Studying vector-borne infectious disease focusing on the biology of vector insects, their genetic diversity and pathogen-vector interactions with special attention to the increasingly limited context of the anti-vector fight which justifies the study of innovative vector control strategies.

3. Exploring the risk of infection in the first years of life, in particular in marginalized and migrant populations for whom childhood, adolescence and maternity stages of live can be particularly fragile. Stages of live where the development of infectious and pathologies are specific to these periods of transition.

4. Studying the impact of aging and longevity on health in the context of epidemiologic transition characterised by most countries. The study of chronic diseases such as metabolic syndromes, cancer, genetic diseases, neurodegenerative conditions, inflammatory diseases are part of the Network’s priorities.

History of the Institut Pasteur

For a historical account of the Institut Pasteur and Louis Pasteur, visit the Institut Pasteur dedicated web page.